Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia

V M M Vorselaars; S Velthuis; M P Huitema; A E Hosman; C J J Westermann; R J Snijder; J J Mager; M C Post

doi:10.1007/s12471-018-1094-4

Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia

Neth Heart J. 2018 Apr;26(4):203-209. doi: 10.1007/s12471-018-1094-4.

Authors

V M M Vorselaars¹, S Velthuis², M P Huitema², A E Hosman³, C J J Westermann³, R J Snijder³, J J Mager³, M C Post²

Affiliations

¹ Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands. [email protected].
² Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands.
³ Department of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands.

Abstract

Aim: Transthoracic contrast echocardiography (TTCE) is recommended for screening of pulmonary arteriovenous malformations (PAVMs) in hereditary haemorrhagic telangiectasia. Shunt quantification is used to find treatable PAVMs. So far, there has been no study investigating the reproducibility of this diagnostic test. Therefore, this study aimed to describe inter-observer and inter-injection variability of TTCE.

Methods: We conducted a prospective single centre study. We included all consecutive persons screened for presence of PAVMs in association with hereditary haemorrhagic telangiectasia in 2015. The videos of two contrast injections per patient were divided and reviewed by two cardiologists blinded for patient data. Pulmonary right-to-left shunts were graded using a three-grade scale. Inter-observer and inter-injection agreement was calculated with κ statistics for the presence and grade of pulmonary right-to-left shunts.

Results: We included 107 persons (accounting for 214 injections) (49.5% male, mean age 45.0 ± 16.6 years). A pulmonary right-to-left shunt was present in 136 (63.6%) and 131 (61.2%) injections for observer 1 and 2, respectively. Inter-injection agreement for the presence of pulmonary right-to-left shunts was 0.96 (95% confidence interval (CI) 0.9-1.0) and 0.98 (95% CI 0.94-1.00) for observer 1 and 2, respectively. Inter-injection agreement for pulmonary right-to-left shunt grade was 0.96 (95% CI 0.93-0.99) and 0.95 (95% CI 0.92-0.98) respectively. There was disagreement in right-to-left shunt grade between the contrast injections in 11 patients (10.3%). Inter-observer variability for presence and grade of the pulmonary right-to-left shunt was 0.95 (95% CI 0.91-0.99) and 0.97 (95% CI 0.95-0.99) respectively.

Conclusion: TTCE has an excellent inter-injection and inter-observer agreement for both the presence and grade of pulmonary right-to-left shunts.

Keywords: Hereditary haemorrhagic telangiectasia; Pulmonary arteriovenous malformation; Pulmonary right-to-left shunt; Transthoracic contrast echocardiography.